PES-HORISONT-EU-PES Horisont Europa
Support Authera to apply for WomenTech EU
Neovascular age-related macular degeneration (nAMD) is a leading cause of vision loss, estimated to affect >50M by 2040. However, up to 40% of patients do not respond well to current treatments or develop resistance over time, driving the need for new options. To meet this need, Authera develops...